secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aridis Pharmaceuticals, Inc. (—)
CIK:        0001614067
Form:       8-K
Filed at:   2023-07-18T23:59:59+00:00
Accession:  0001493152-23-024769
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Aridis receives Nasdaq delisting notice; shares to trade on OTC Pink Sheets from July 19
--------------------------------------------------------------------------------

- Nasdaq notified Aridis on July 17, 2023 that its common stock will be delisted from the Nasdaq Capital Market.
- Delisting becomes effective at the opening of trading on July 19, 2023.
- Company expects shares to trade on OTC Pink Sheets; will seek market makers to provide liquidity.
- No assurance that an active trading market for shares will develop post-delisting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1614067/000149315223024769/0001493152-23-024769-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1614067/000149315223024769/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-024769

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer